Migraine Drugs Market – Opportunities & Forecast, 2020 - 2027

The global migraine drugs market forecast 2020-2027 report provides comprehensive coverage of the market through market segments, in-depth regional level analysis, and identifies the key drivers, restraints, growth opportunities, and competitive scenarios in the market. The global migraine drugs market report offers extensive insight and analysis of the market over the next six years (2020-2027) and evaluates the impact of the COVID-19 outbreak on the industry.

Global Migraine Drugs Market Overview

The increasing prevalence of migraine in the age group of 30 to 40 is the key driver boosting the growth of the migraine drugs market size. The increasing female population and growing awareness among patients related to the prevention and treatment of migraines will further surge the demand for the migraine drugs market. On the other hand, the side effects such as fatigue, nausea, lowering of blood pressure, etc., associated with the regular consumption of migraine drugs are likely to hamper the growth of the market over the coming years.

Global Migraine Drugs Market Competitive Rivalry

The global migraine drugs market report includes an analysis of the competitive landscape present in the global migraine drugs market. It includes an assessment of the existing and upcoming trends that players can invest in. The leading players in the global migraine drugs market are Aerial Biopharma LLC, Alder Biopharmaceuticals Inc., Amgen Inc, Johnsons and Johnsons, Astellas Pharma, Abbott Laboratories, Aegis Therapeutics, LLC, AstraZeneca, Eisai Co Ltd, and Eli Lily & Co, among others.

Global Migraine Drugs Market Segmentation

On the basis of drug type, the global migraine drugs market report represents the market share, revenue, and growth rate of each drug type, which is further divided into

• Abortive Drugs
• Preventive Drugs

On the basis of route of administration, the global migraine drugs market report studies the market share, revenue, and growth rate of each route of administration, which is further divided into

• Oral
• Injectables
• Others (Nasal Spray, Transdermal Path, etc.)

On the basis of end user, the global migraine drugs market report studies the market share, revenue, and growth rate of each end user, which is further divided into

• Hospitals Pharmacies
• Retail Pharmacies
• Others

Geographic Segmentation

The global migraine drugs market report splits the market into North America, Europe, Asia Pacific, and the Rest of the World, with revenue, market share, and growth rate of all of these regions, from 2020-2027:

• North America
  • United States of America
  • Canada

• Asia Pacific

• China
• Japan
• India
• Rest of APAC

• Europe

• United Kingdom
• Germany
• France
• Spain
• Rest of Europe

• RoW

• Brazil
• South Africa
• Saudi Arabia
• UAE
• Rest of the world (remaining countries of the LAMEA region)

About GMI Research

GMI Research is a market research and consulting firm which provides bespoke industry & market research to help businesses in making the toughest business decision. We know the significance of accurate data; that’s why our analyst uses a tailored methodology to study everay market in detail because one size doesn’t fit all. We not only cover the traditional well-established market but also focuses on the niche market and markets in the emerging economies, where getting data and information is a challenge. This factor makes us pioneer in emerging market research space. Our syndicate reports cover multiple industries across various regions and countries.

Our in-depth market reports help propel your business with all the data, strategic inputs, and competitive intelligence to move ahead even in the most uncertain times. Featured in the ‘Top 20 Most Promising Market Research Consultants’ list of Silicon India Magazine in 2018, we at GMI Research look forward to help businesses stay ahead of the curve.